Universus Imagings Peer Comparison

NSE: UNIVPHOTO | BSE: 542933

₹452.00

₹-0.80 (-0.18%)

As on 13-Nov-2026 11:00IST

Market cap

₹496 Cr

Revenue (TTM)

₹19 Cr

P/E Ratio

P/B Ratio

0.6

Div. Yield

0 %

Edit

	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure	Medplus Health
Market cap (₹ Cr)	496	492	54,712	17,002	7,561
Revenue (₹ Cr)	19	75	7,072	2,134	7,587
Net Profit (₹ Cr)	17.29	21.73	1,235.87	309.79	211.00
Net Margin (%)	47.19	27.10	16.75	13.89	2.75
RoE (%)	-2.13	18.08	11.91	9.92	10.44
Price to Earnings	--	22.65	44.27	53.40	35.83
Price-To-Book	0.61	3.77	5.12	5.21	3.66

Income Statement (₹ Cr)

	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure	Medplus Health
Operating Revenue	19.29	75.11	7,072.01	2,134.07	7,587.21
Total Income	36.64	80.18	7,376.93	2,230.51	7,666.42
Total Expenditure	18.24	48.95	5,150.71	1,649.83	6,956.12
EBITDA	1.05	26.16	1,921.31	484.24	631.09
Depreciation	0.12	2.04	442.58	138.29	310.44
EBIT	0.93	24.12	1,478.73	345.95	320.65
Interest	0.00	0.00	25.46	26.02	134.20
Other Income	17.35	5.06	304.92	96.44	79.21
Exceptional Items	0.00	0.00	-24.35	2.76	0.00
Profit before Tax	18.28	29.19	1,733.84	419.13	265.65
Provision for Tax	0.99	7.46	497.98	109.35	54.66
Profit after Tax	17.29	21.73	1,235.87	309.79	211.00

	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure	Medplus Health
Shareholder's Funds	811.21	124.80	10,685.67	3,265.35	2,068.28
Minority Interest	0.00	0.00	0.00	2.13	0.04
Non-Current Liabilities	12.72	1.25	527.10	198.36	1,361.51
Current Liabilities	1.06	7.14	1,713.97	649.28	768.76
Total Liabilities	824.99	--	12,448.52	3,951.60	4,084.80

	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure	Medplus Health
Non-Current Assets	548.29	26.70	4,881.90	2,006.37	558.11
Current Assets	276.48	106.49	7,872.33	2,033.02	2,178.89
Total Assets	824.99	--	12,448.52	3,951.60	4,084.80
Total Debt*	0.00	--	243.36	341.62	0.00
Net Current Assets	275.42	99.35	6,158.36	1,383.74	1,410.13
Contingent Liabilities	2.90	--	10.12	50.21	14.06

	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure	Medplus Health
Cash From Operating Activities	2.05	--	1,031.39	246.37	495.58
Cash Flow from Investing Activities	-2.06	--	137.73	-225.38	-127.72
Cash from Financing Activities	--	--	-416.97	20.15	-255.51
Net Cash Inflow / Outflow	0.00	--	752.14	41.14	112.36

	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure	Medplus Health
ROCE (%)	-9.33	--	14.96	14.05	22.22
ROE (%)	-2.13	18.08	11.91	9.92	10.44
ROA (%)	2.01	17.68	10.00	8.00	5.43
EBIT Margin (%)	4.82	32.11	20.91	16.21	4.23
Net Margin (%)	47.19	27.10	16.75	13.89	2.75
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure	Medplus Health
Revenue Growth (%)	-5.21	14.78	21.90	24.64	20.57
EBIT Growth (%)	131.53	15.04	49.42	-4.98	11.48
Net Profit Growth (%)	-50.44	15.03	56.36	-12.90	8.18
EPS Growth (%)	-121.46	15.03	58.48	-12.71	7.89
Book Value Growth (%)	-7.21	--	12.70	12.14	14.76

	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure	Medplus Health
Price / Earnings	-28.18	23.09	43.50	54.30	35.57
Price / Book Value	0.61	3.85	5.11	5.26	3.63
Dividend Yield (%)	0.00	0.24	0.60	0.21	0.00
EV/EBITDA	212.21	16.06	26.78	34.44	11.18
Market Cap (₹ Cr)	511.04	--	27,964.97	12,069.92	10,057.49

	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure	Medplus Health
Debt to Equity	0.00	0.00	0.01	0.01	0.00
Short term debt to equity ratio	--	--	--	0.08	--
Current Ratio	260.83	14.91	4.59	3.13	2.83
Quick Ratio	259.03	13.39	3.53	2.34	0.86
Interest Coverage	0.00	--	69.10	17.11	2.98

	Universus Imagings	Prevest Denpro	Gland Pharma	Poly Medicure	Medplus Health
Debtors to sales (%)	1.81	11.60	27.25	26.19	0.51
Asset Turnover	0.02	0.61	0.57	0.55	1.95
Receivable days	15.02	--	96.72	85.20	1.05
Inventory Days	74.40	--	97.32	69.58	71.25
Payable days	13.26	--	134.60	77.97	21.75
Cash Conversion Cycle	76.16	--	59.43	76.82	50.55

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.